Your browser is no longer supported. Please, upgrade your browser.
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E28.35 EPS (ttm)5.40 Insider Own0.10% Shs Outstand2.63B Perf Week-5.95%
Market Cap413.29B Forward P/E14.94 EPS next Y10.25 Insider Trans-1.98% Shs Float2.60B Perf Month-5.07%
Income14.41B PEG5.34 EPS next Q2.32 Inst Own69.90% Short Float0.59% Perf Quarter3.81%
Sales82.58B P/S5.00 EPS this Y-4.20% Inst Trans-0.19% Short Ratio1.84 Perf Half Y1.02%
Book/sh24.04 P/B6.37 EPS next Y7.91% ROA8.90% Target Price185.44 Perf Year6.68%
Cash/sh9.33 P/C16.41 EPS next 5Y5.31% ROE23.40% 52W Range109.16 - 173.65 Perf YTD-2.74%
Dividend4.04 P/FCF42.57 EPS past 5Y-0.30% ROI14.60% 52W High-11.85% Beta0.71
Dividend %2.64% Quick Ratio1.00 Sales past 5Y3.30% Gross Margin65.70% 52W Low40.23% ATR3.13
Employees134500 Current Ratio1.20 Sales Q/Q8.30% Oper. Margin20.00% RSI (14)31.16 Volatility2.12% 1.55%
OptionableYes Debt/Eq0.56 EPS Q/Q-56.60% Profit Margin17.80% Rel Volume1.34 Prev Close156.22
ShortableYes LT Debt/Eq0.52 EarningsJan 26 BMO Payout71.20% Avg Volume8.29M Price153.07
Recom1.90 SMA20-6.03% SMA50-4.87% SMA2001.84% Volume11,033,178 Change-2.02%
Apr-28-20Downgrade UBS Buy → Neutral $163 → $160
Apr-22-20Upgrade BofA/Merrill Neutral → Buy $150 → $175
Mar-05-20Initiated Citigroup Buy $163
Dec-19-19Upgrade Barclays Equal Weight → Overweight $173
Dec-17-19Upgrade Morgan Stanley Equal-Weight → Overweight $145 → $170
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Mar-05-21 04:53AM  
03:17AM  
Mar-04-21 11:44PM  
09:48PM  
05:00PM  
04:31PM  
04:30PM  
03:57PM  
02:44PM  
02:32PM  
02:06PM  
12:18PM  
11:57AM  
10:41AM  
10:17AM  
10:10AM  
09:54AM  
09:19AM  
06:12AM  
Mar-03-21 06:16PM  
04:00PM  
03:16PM  
02:35PM  
02:18PM  
01:23PM  
01:00PM  
12:36PM  
12:05PM  
12:04PM  
11:57AM  
11:49AM  
11:24AM  
10:55AM  
10:41AM  
08:53AM  
08:46AM  
07:20AM  
07:13AM  
06:48AM  
06:14AM  
06:02AM  
Mar-02-21 06:00PM  
05:45PM  
04:23PM  
04:15PM  
04:00PM  
03:51PM  
02:14PM  
02:00PM  
01:24PM  
12:21PM  
12:12PM  
11:46AM  
10:58AM  
10:36AM  
10:32AM  
10:22AM  
09:15AM  
09:12AM  
09:09AM  
08:16AM  
08:08AM  
07:18AM  
05:12AM  
04:41AM  
03:41AM  
01:49AM  
Mar-01-21 07:17PM  
05:38PM  
05:14PM  
05:09PM  
05:05PM  
05:00PM  
04:34PM  
04:18PM  
04:17PM  
04:16PM  
04:10PM  
04:00PM  
04:00PM  
03:44PM  
03:20PM  
02:58PM  
02:52PM  
02:46PM  
02:42PM  
02:28PM  
01:50PM  
01:47PM  
01:45PM  
12:39PM  
12:35PM  
11:56AM  
11:45AM  
11:20AM  
11:07AM  
10:32AM  
10:27AM  
09:58AM  
09:00AM  
Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stoffels PaulusVice Chair, Exec CommitteeFeb 12Option Exercise0.0035,0620289,864Feb 17 07:09 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 12Option Exercise0.0013,6060121,191Feb 17 07:09 PM
Ullmann Michael HExec VP, General CounselFeb 12Option Exercise0.0014,4440157,728Feb 17 07:09 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 12Option Exercise0.0010,362068,837Feb 17 07:09 PM
Wolk Joseph JExec VP, CFOFeb 12Option Exercise0.005,086024,513Feb 17 07:09 PM
Decker Robert JController, CAOFeb 12Option Exercise0.001,310014,701Feb 17 07:09 PM
Gorsky AlexChairman, CEOFeb 12Option Exercise0.0075,1050507,925Feb 17 07:09 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 12Option Exercise0.007,145042,960Feb 17 07:09 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 12Option Exercise0.0033,0210209,490Feb 17 07:09 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 12Option Exercise0.0012,8730113,039Feb 17 07:09 PM
Sneed Michael EEVP, Global Corp Aff & CCOFeb 12Option Exercise0.009,211065,290Feb 17 07:09 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 12Option Exercise0.0013,136034,834Feb 17 07:09 PM
Sneed Michael EEVP, Global Corp Aff & COODec 09Option Exercise62.2054,6623,399,976110,741Dec 10 06:19 PM
Sneed Michael EEVP, Global Corp Aff & COODec 09Sale152.9354,6628,359,46056,079Dec 10 06:19 PM
Wengel Kathryn EEVP, Chief GSC OfficerSep 02Option Exercise63.7516,1151,027,32374,535Sep 04 02:58 PM
Wengel Kathryn EEVP, Chief GSC OfficerSep 02Sale153.5216,1152,473,93858,420Sep 04 02:58 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesJul 28Sale147.4729,0004,276,63021,682Jul 28 06:43 PM
JOHNSON & JOHNSON10% OwnerJun 30Buy17.00725,00012,325,0003,670,516Jul 02 04:58 PM
PEREZ WILLIAM DDirectorMar 13Buy127.6950063,84316,030Mar 17 04:24 PM